Experian
social positive data in brazil impact large adult population people will benefit significant score benefits population millions people will benefit from positive data of people with current access to credit will see significant improvements to their score brazil population is comprised of adults and children of the adults are banked and are unbanked of the adults we expect will benefit from positive data this is comprised of people who already have good scores and access to credit but would benefit to a greater or lesser degree from more information available people who currently don have a score good enough to get credit but don have a record of missed payments in the negative data file and so should benefit from positive data which should boost their score and get them into the credit market the remaining people won benefit currently because they have a record of many missed payments in the negative data file of the with current access to credit who will benefit from positive data we expect are expected to see a significant score improvement from positive data potentially getting lower interest rates remaining won see significant score increases either because they already have very high scores so the benefit from positive data will be small and won change interest rates they have unpaid debt whilst they still have a good enough score to get credit the unpaid debt would prevent them getting access to lower interest rates | Experian
Company
Deck Type
ESG
Sector
Industry
Deck date
June 2022
Slide
27 of 91
Related slides by other companies
AstraZeneca
Results
November 2024
oncology highlights continuing momentum across oncology with data at key medical congresses in and expanding into bladder cancer and advancing next gen and advancing with upcoming data at ash only regimen to show benefit potential new soc patients amplify fixed duration in clinically meaningful improvement trend to benefit ineligible phase next wave in house novel high rate in high levels of complete remission in good tolerability | AstraZeneca
AvePoint
Investor Presentation
November 2021
why we win depth and breadth of platform approach benefits a | AvePoint
AvePoint
SPAC
November 2021
why we win depth and breadth of platform approach benefits a | AvePoint
Ocuphire Pharma
Results
June 2021
to cadence of milestones | Ocuphire Pharma
Other recent decks by Experian
See all presentations (4 decks)
Investor Presentation
July 2022
Results
May 2022
Investor Conference
September 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io